Brivanib (BMS-540215)
Brivanib (BMS-540215) (S1084-GRP)
Products
Description
Brivanib is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, moderate potency against VEGFR-1 and FGFR-1, but >240-fold against PDGFR-β. Phase 3.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | S1084 |
| Target | FGFR |